Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
James Isaacs, Carey K. Anders, Heather L. McArthur, Jeremy Force
Topics & Concepts
MedicineAtezolizumabTriple-negative breast cancerImmune checkpointOncologyBreast cancerBiomarkerImmunotherapyInternal medicineMetastatic breast cancerClinical trialCancerPembrolizumabBiochemistryChemistryCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune ResponseCancer Cells and Metastasis